Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
Open accessAbstract
We previously demonstrated that rAAV vectors carrying human and canine factor IX (FIX) cDNA can infect, stably persist, and secrete functional human and canine FIX following direct intramuscular injection. In an attempt to improve FIX protein secretion for eventual therapeutic use, we set out to determine if alteration of the AAV capsid would affect skeletal muscle transduction and factor IX secretion. Two reasons to pursue this question were (1) the persistence of high-titer neutralizing antibody (NAB) to AAV2 and (2) our previous study that supported a restricted tropism of muscle fiber types to AAV2 transduction. Using an identical CMV/canine factor IX (cFIX) expression cassette, we cross-packaged this genome into virions generated from each of the five AAV serotypes. In a dose-response assay, equivalent amounts of rAAV/cFIX serotypes were tested in vitro and in vivo. In tissue culture cells, FIX antigen levels secreted into the supernatant varied depending on the AAV serotype used; type 2 transduced maximally, with serotypes 3, 1, 5, and 4, respectively, expressing lower levels. However, when the same viruses were tested in vivo using immunodeficient NOD/SCID animals, we obtained surprisingly different results. While the time to onset of detectable serum levels appeared the same for all serotypes, types 1, 3, and 5 produced 100- to 1000-fold more cFIX than type 2. In fact, 12 weeks after transduction, type 1 continued to express levels of cFIX on average at 80 microg/ml followed by type 5 (6.52 microg/ml), type 3 (3.27 microg/ml), type 4 (258 ng/ml), and finally type 2 (90 ng/ml). Coagulant activity of cFIX as measured by aPTT supported the circulating levels measured by ELISA demonstrating the secreted protein was functional, and RT-PCR of injected tissue correlated with the serotype-specific transduction data. In summary, we found significant differences in cFIX expression upon introducing various rAAV serotypes into mouse muscle. These data have direct bearing on the design of AAV gene therapy clinical trials for hemophilia and should also extend to most therapeutic transgenes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The capsid-cell surface interaction is the primary determinant of AAV tropism.
“Although it is possible to utilize promoter elements that limit transgene expression to specific cellular lineages, the capsid-cell surface interaction is the primary determinant of AAV tropism.”
From Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease (2021) · cites this paper as [1]
Cites
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,862 · see citing works
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409 · see citing works
Self-citationDavidson, B. L., Stein, C. S., Heth, J., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050581197 · Cited by 679 · see citing works
Kessler, P., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614 · see citing works
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541 · see citing works
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531 · see citing works
Herzog, R. W., Hagstrom, J. N., Kung, S.-H., Tai, S. J., Wilson, J. M., Fisher, K. J., & High, K. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5804 · Cited by 474 · see citing works
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452 · see citing works
Cloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L. C., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332 · see citing works
Halbert, C. L., Rutledge, E. A., Allen, J. M., Russell, D. W., & Miller, A. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1524-1532.2000 · Cited by 259 · see citing works
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231 · see citing works
Self-citationThe Development of Human Gene Therapy
Nabel, E. G. (1999) · Nature Medicine · doi:10.1038/10443 · Cited by 165 · see citing works
Adeno-associated virus expression systems for gene transfer
Rabinowitz, J. E., & Samulski, J. R. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80031-1 · Cited by 140 · see citing works
Self-citationPersistent expression of canine factor IX in hemophilia B canines
Chao, H., Samulski, R. J., Bellinger, D. A., Monahan, P. E., Nichols, T. C., & Walsh, C. E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301024 · Cited by 103 · see citing works
Self-citationPruchnic, R., Cao, B., Peterson, Z. Q., Xiao, X., Li, J., Samulski, R. J., Epperly, M., & Huard, J. (2000) · Human Gene Therapy · doi:10.1089/10430340050015716 · Cited by 86 · see citing works
Self-citationAdeno-associated Viral Vectors
Samulski, R. J. (1995) · Springer eBooks · doi:10.1007/978-94-011-0555-2_3 · Cited by 59 · see citing works
Self-citationHerzog, R. W., & High, K. A. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615877 · Cited by 30 · see citing works
Flagged first, then by citations
1 of the 18 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520 · see citing works
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · see citing works
Self-citationAdeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 921 · see citing works
Self-citationTherapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · see citing works
Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762 · see citing works
Self-citationAAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749 · see citing works
Burger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741 · see citing works
Gene therapy: twenty-first century medicine.
Verma, I., & Weitzman, M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 641 · see citing works
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 602 · see citing works
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Philipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 556 · see citing works
Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping
Goyenvalle, A., Vulin, A., Fougerousse, F., Leturcq, F., Kaplan, J., Garcı́a, L., & Danos, O. (2004) · Science · doi:10.1126/science.1104297 · Cited by 504 · see citing works
Cearley, C. N., & Wolfe, J. H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.015 · Cited by 409 · see citing works
Auricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 394 · see citing works
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S. H., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 360 · see citing works
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358 · see citing works
Grimm, D., & Kay, M. A. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 349 · see citing works
Grimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344 · see citing works
Flotte, T. R., Trapnell, B. C., Humphries, M., Carey, B., Calcedo, R., Rouhani, F., Campbell-Thompson, M., Yachnis, A. T., Sandhaus, R. A., McElvaney, N. G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.053 · Cited by 335 · see citing works
Wu, Z., Miller, E. B., Agbandje‐McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00895-06 · Cited by 327 · see citing works
Self-citationUnrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice
Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S., Nara, Y., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.214-224.2005 · Cited by 322 · see citing works
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 319 · see citing works
Clinical gene therapy using recombinant adeno-associated virus vectors
Mueller, C., & Flotte, T. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.68 · Cited by 312 · see citing works
Hastie, E. L., & Samulski, R. J. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.025 · Cited by 284 · see citing works
Self-citationViral vectors for gene delivery to the central nervous system
Lentz, T. B., Gray, S. J., & Samulski, R. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.014 · Cited by 274 · see citing works
Self-citationRivera, V. M., Gao, G., Grant, R. L., Schnell, M. A., Zoltick, P. W., Rozamus, L. W., Clackson, T., & Wilson, J. M. (2004) · Blood · doi:10.1182/blood-2004-06-2501 · Cited by 272 · see citing works
Smith, R. H., Levy, J. R., & Kotin, R. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.128 · Cited by 260 · see citing works
Intracellular transport of recombinant adeno-associated virus vectors
Nonnenmacher, M., & Weber, T. (2012) · Gene Therapy · doi:10.1038/gt.2012.6 · Cited by 258 · see citing works
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
Blankinship, M. J., Gregorevic, P., Allen, J. M., Harper, S. Q., Harper, H. A., Halbert, C. L., Miller, A. D., & Chamberlain, J. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.016 · Cited by 250 · see citing works
Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell‐Thompson, M., Crawford, J. M., Shek, E. W., Scarpace, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2333912100 · Cited by 244 · see citing works
Mori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 240 · see citing works
Salva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300027 · Cited by 232 · see citing works
Lu, Q. L., Liang, H.-D., Partridge, T. A., & Blomley, M. J. K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301913 · Cited by 231 · see citing works
Yan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222 · see citing works
Advances in Duchenne muscular dystrophy gene therapy
van Deutekom, J. C. T., & van Ommen, G. B. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1180 · Cited by 220 · see citing works
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 216 · see citing works
Passini, M. A., Watson, D. J., Vite, C. H., Landsburg, D. J., Feigenbaum, A. L., & Wolfe, J. H. N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7034-7040.2003 · Cited by 213 · see citing works
VandenDriessche, T., Thorrez, L., Acosta‐Sanchez, A., Petrus, I., Wang, L., Ma, L., Waele, L. D., Iwasaki, Y., Gillijns, V., Wilson, J. M., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02220.x · Cited by 210 · see citing works
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Yang, L., Jiang, J., Drouin, L. M., Agbandje‐McKenna, M., Chen, C., Qiao, C., Pu, D., Hu, X., Wang, D.-Z., Li, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813207106 · Cited by 208 · see citing works
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4
Govindasamy, L., Padron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., & Agbandje-McKenna, M. (2006) · Journal of Virology · doi:10.1128/jvi.01536-06 · Cited by 205 · see citing works
Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer
Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N. B., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6199-6203.2001 · Cited by 204 · see citing works
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203 · see citing works
Self-citationAdeno-Associated Virus Vectorology, Manufacturing, and Clinical Applications
Grieger, J. C., & Samulski, R. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00012-0 · Cited by 199 · see citing works
Self-citationRivière, C., Danos, O., & Douar, A. M. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302766 · Cited by 192 · see citing works
Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver
Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190 · see citing works
Adeno-Associated Virus (AAV) Vectors in the CNS
McCown, T. J. (2005) · Current Gene Therapy · doi:10.2174/1566523054064995 · Cited by 187 · see citing works
Comparison of AAV Serotypes for Gene Delivery to Dorsal Root Ganglion Neurons
Mason, M. R. J., Ehlert, E., Eggers, R., Pool, C. W., Hermening, S., Huseinovic, A., Timmermans, E., Blits, B., & Verhaagen, J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.19 · Cited by 183 · see citing works
Non-viral gene delivery in skeletal muscle: a protein factory
Lu, Q. L., Bou–Gharios, G., & Partridge, T. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301874 · Cited by 183 · see citing works
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
Mah, C., Fraites, T. J., Zolotukhin, I., Song, S.-H., Flotte, T., Dobson, J., Batich, C., & Byrne, B. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0636 · Cited by 180 · see citing works
Wang, L., Calcedo, R., Nichols, T. C., Bellinger, D. A., Dillow, A., Verma, I. M., & Wilson, J. M. (2005) · Blood · doi:10.1182/blood-2004-10-3867 · Cited by 173 · see citing works
Kwon, I., & Schaffer, D. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9431-0 · Cited by 164 · see citing works
Schmidt, M., Voutetakis, A., Afione, S. A., Zheng, C., Mandikian, D., & Chiorini, J. A. (2007) · Journal of Virology · doi:10.1128/jvi.02012-07 · Cited by 162 · see citing works
Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics
Rayaprolu, V., Kruse, S., Kant, R., Venkatakrishnan, B., Movahed, N., Brooke, D. J., Lins, B., Bennett, A. D., Potter, T., McKENNA, R. V., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01415-13 · Cited by 161 · see citing works
Generation and characterization of chimeric recombinant AAV vectors
Hauck, B., Chen, L., & Xiao, W. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00012-1 · Cited by 160 · see citing works
Miller, T. M., Kim, S. H., Yamanaka, K., Hester, M. E., Umapathi, P., Arnson, H. A., Rizo, L., Mendell, J. R., Gage, F. H., Cleveland, D. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609411103 · Cited by 159 · see citing works
Gene Therapy Progress and Prospects: Recombinant adeno-associated virus (rAAV) vectors
Flotte, T. R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302233 · Cited by 159 · see citing works
Thermal Stability as a Determinant of AAV Serotype Identity
Bennett, A. D., Patel, S., Mietzsch, M., Jose, A., Lins, B., Yu, J. C., Bothner, B. B., McKENNA, R. V., & Agbandje‐McKenna, M. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.07.003 · Cited by 157 · see citing works
Treatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155 · see citing works
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins
Auricchio, A., O’Connor, E., Weiner, D. J., Gao, G., Hildinger, M., Wang, L., Calcedo, R., & Wilson, J. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15780 · Cited by 150 · see citing works
Arruda, V. R., Schüttrumpf, J., Herzog, R. W., Nichols, T. C., Robinson, N. A., Lotfi, Y., Mingozzi, F., Xiao, W., Couto, L. B., & High, K. A. (2003) · Blood · doi:10.1182/blood-2003-05-1446 · Cited by 149 · see citing works
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Tenenbaum, L., Lehtonen, E., & Monahan, P. E. (2003) · Current Gene Therapy · doi:10.2174/1566523034578131 · Cited by 146 · see citing works
Versatility of AAV vectors for retinal gene transfer
Surace, E. M., & Auricchio, A. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.027 · Cited by 145 · see citing works
Warnock, J. N., Daigre, C., & Al‐Rubeai, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-095-9_1 · Cited by 140 · see citing works
Efficacy of an Adeno-associated Virus 8-Pseudotyped Vector in Glycogen Storage Disease Type II
Sun, B., Zhang, H., Franco, L. M., Young, S. P., Schneider, A., Bird, A., Amalfitano, A., Chen, Y.-T., & Koeberl, D. D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.004 · Cited by 140 · see citing works
Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain
Wang, C., Wang, C.-M., Clark, K. R., & Sferra, T. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302011 · Cited by 139 · see citing works
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
Denti, M. A., Rosa, A., D’Antona, G., Sthandier, O., Angelis, F. G. D., Nicoletti, C., Allocca, M., Pansarasa, O., Parente, V., Musarò, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508917103 · Cited by 139 · see citing works
Grieger, J. C., & Samulski, R. J. (2005) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_005 · Cited by 136 · see citing works
Self-citationDu, L., Zhao, G., Lin, Y., Sui, H., Chan, C. C. S., Ma, S., He, Y., Jiang, S., Wu, C. Y., Yuen, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.948 · Cited by 136 · see citing works
Gene therapy of muscular dystrophy
Chamberlain, J. S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2355 · Cited by 136 · see citing works
Fraites, T. J., Schleissing, M. R., Shanely, R. A., Walter, G. A., Cloutier, D. A., Zolotukhin, I., Pauly, D. F., Raben, N., Plötz, P. H., Powers, S. K., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0580 · Cited by 136 · see citing works
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo
Palomeque, J., Chemaly, E. R., Colosi, P., Wellman, J. A., Zhou, S. Z., del Monte, F., & Hajjar, R. J. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302895 · Cited by 135 · see citing works
Watchko, J. F., O’Day, T., Wang, B., Zhou, L., Tang, Y. M., Li, J., & Xiao, X. (2002) · Human Gene Therapy · doi:10.1089/10430340260185085 · Cited by 130 · see citing works
Bantel‐Schaal, U., Hub, B., & Kartenbeck, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2340-2349.2002 · Cited by 127 · see citing works
Characterization of Tissue Tropism Determinants of Adeno-Associated Virus Type 1
Hauck, B., & Xiao, W. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2768-2774.2003 · Cited by 124 · see citing works
Lewis, A. D., Chen, R., Montefiori, D. C., Johnson, P. R., & Clark, K. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8769-8775.2002 · Cited by 124 · see citing works
Efficient Retrograde Neuronal Transduction Utilizing Self-complementary AAV1
Hollis, E. R., II, Kadoya, K., Hirsch, M. L., Samulski, R. J., & Tuszynski, M. H. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300367 · Cited by 124 · see citing works
Self-citationHalbert, C. L., Allen, J. M., & Miller, A. D. (2002) · Nature Biotechnology · doi:10.1038/nbt0702-697 · Cited by 121 · see citing works
Gene therapy: The first two decades and the current state‐of‐the‐art
Flotte, T. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21173 · Cited by 117 · see citing works
Building a Better Vector: The Manipulation of AAV Virions
Rabinowitz, J. E., & Samulski, R. J. (2000) · Virology · doi:10.1006/viro.2000.0707 · Cited by 117 · see citing works
Self-citationBurova, E., & Ioffe, E. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302611 · Cited by 115 · see citing works
Chao, H., Monahan, P. E., Liu, Y., Samulski, R. J., & Walsh, C. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0449 · Cited by 115 · see citing works
Self-citationImmunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain
Mastakov, M. Y., Baer, K., Symes, C. W., Leichtlein, C. B., Kotin, R. M., & During, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8446-8454.2002 · Cited by 114 · see citing works
The Role of the Adeno-Associated Virus Capsid in Gene Transfer
Vliet, K. V., Blouin, V., Brument, N., Agbandje‐McKenna, M., & Snyder, R. O. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-210-6_2 · Cited by 113 · see citing works
Pajusola, K., Gruchała, M., Joch, H., Lüscher, T. F., Ylä‐Herttuala, S., & Büeler, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11530-11540.2002 · Cited by 111 · see citing works
Smith-Arica, J. R., Thomson, A. J., Ansell, R., Chiorini, J. A., Davidson, B. L., & McWhir, J. (2003) · Cloning and Stem Cells · doi:10.1089/153623003321512166 · Cited by 111 · see citing works
Adeno-associated viral vectors do not efficiently target muscle satellite cells
Arnett, A. L. H., Konieczny, P., Ramos, J. N., Hall, J. K., Odom, G., Yablonka‐Reuveni, Z., Chamberlain, J. R., & Chamberlain, J. S. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.38 · Cited by 110 · see citing works
Adeno-associated virus vectors: potential applications for cancer gene therapy
Li, C., Bowles, D. E., Dyke, T. V., & Samulski, R. J. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700876 · Cited by 110 · see citing works
Self-citationYan, Z., Zak, R., Zhang, Y., & Engelhardt, J. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.364-379.2005 · Cited by 107 · see citing works
Fabb, S. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.7.733 · Cited by 103 · see citing works
Chen, S., Kapturczak, M., Loiler, S., Zolotukhin, S., Glushakova, O. Y., Madsen, K., Samulski, R. J., Hauswirth, W. W., Campbell‐Thompson, M., Berns, K. I., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.235 · Cited by 102 · see citing works
Self-citationXu, L., Gao, C., Sands, M. S., Cai, S., Nichols, T. C., Bellinger, D. A., Raymer, R. A., McCorquodale, S., & Ponder, K. P. (2003) · Blood · doi:10.1182/blood-2002-10-3050 · Cited by 101 · see citing works
Fewell, J. G., MacLaughlin, F. C., Mehta, V. P., Gondo, M., Nicol, F., Wilson, E., & Smith, L. C. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0295 · Cited by 100 · see citing works
Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site
Huang, L.-Y., Patel, A. R., Ng, R., Miller, E. B., Halder, S., McKENNA, R. V., Asokan, A., & Agbandje‐McKenna, M. (2016) · Journal of Virology · doi:10.1128/jvi.00161-16 · Cited by 99 · see citing works
Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P. L., Nam, H.-J., Agbandje‐McKenna, M., & Wilson, J. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803965 · Cited by 98 · see citing works
MiRNA inhibition in tissue engineering and regenerative medicine
Beavers, K. R., Nelson, C. E., & Duvall, C. L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.006 · Cited by 98 · see citing works
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
Cardone, M., Polito, V. A., Pepe, S., Mann, L., d’Azzo, A., Auricchio, A., Ballabio, A., & Cosma, M. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl038 · Cited by 97 · see citing works
Li, C., Diprimio, N., Bowles, D. E., Hirsch, M. L., Monahan, P. E., Asokan, A., Rabinowitz, J., Agbandje-McKenna, M., & Samulski, R. J. (2012) · Journal of Virology · doi:10.1128/jvi.00675-12 · Cited by 96 · see citing works
Self-citationAAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Mitchell, A. M., Nicolson, S. C., Warischalk, J. K., & Samulski, R. J. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 96 · see citing works
Self-citationPaterna, J., Feldon, J., & Büeler, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6808-6817.2004 · Cited by 96 · see citing works
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
Odom, G. L., Gregorevic, P., & Chamberlain, J. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.007 · Cited by 95 · see citing works
Urabe, M., Xin, K.-Q., Obara, Y., Nakakura, T., Mizukami, H., Kume, A., Okuda, K., & Ozawa, K. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.024 · Cited by 94 · see citing works
- Authors
- Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Walsh, Christopher E.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 2
- Issue
- 6
- Pages
- 619-623
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2050245606
- Cited by
- 366
- References
- 18
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 13 · 2014: 12 · 2013: 8 · 2012: 10
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk054419-04, 5r01hl048347-09)
- National Heart, Lung, and Blood Institute (HL 48347)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54419)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus serotypes, skeletal muscle transduction, neutralizing antibodies, intramuscular injection, coagulant activity
- MeSH terms
- Dependovirus, Animals, Dogs, Factor IX, Genetic Vectors, Transduction, Genetic, Mice, SCID, Mice, Inbred NOD, Transgenes, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review